Forge Biologics' Gene Therapy Shows Positive Signals in Krabbe Disease
Forge Biologics' novel gene therapy for Krabbe disease, a fatal neurodegenerative disorder, showed positive signals in a Phase I/II trial.
Source: biospace.com
Stay updated with breaking news from Ohio Based Forge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Forge Biologics' novel gene therapy for Krabbe disease, a fatal neurodegenerative disorder, showed positive signals in a Phase I/II trial.
The biggest biotech financing of the past week belongs to a startup developing an immunology drug that could rival blockbuster products sold by big pharmaceutical companies. Cell therapy, cancer, and rare disease also figured into this week’s startup cash hauls.